Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study
出版年份 2019 全文链接
标题
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study
作者
关键词
-
出版物
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume -, Issue -, Pages 1-8
出版商
Informa UK Limited
发表日期
2019-09-27
DOI
10.1080/09546634.2019.1671577
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Secukinumab Drug Survival in Patients with Psoriasis: A multicenter, real-world, retrospective study
- (2019) Tiago Torres et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A prospective multi-center study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients
- (2019) José María Ortiz Salvador et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long‐term continuation with secukinumab in psoriasis: association with patient profile and initial psoriasis clearance
- (2019) L. Ferrières et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study
- (2019) Matteo Megna et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry
- (2019) Bruce E. Strober et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Psoriasis treat to target: defining outcomes in psoriasis using data from a real world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR )
- (2019) S.K. Mahil et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
- (2018) A. Egeberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation
- (2018) Marco Galluzzo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Drug survival of secukinumab for psoriasis in a real-world setting
- (2018) Erica B. Lee et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study
- (2018) Jorge R. Georgakopoulos et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Real-life efficacy and safety of secukinumab: results from a tertiary hospital in Greece
- (2018) A. Tsentemeidou et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study)
- (2018) R. Bissonnette et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
- (2018) Andrew Blauvelt et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain
- (2018) Jaime Notario et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Secukinumab survival and long-term efficacy in patients with plaque psoriasis: real-life data from a tertiary hospital in Greece
- (2018) E. Sotiriou et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long-term clinical efficacy and safety of secukinumab for Japanese patients with psoriasis: A single-center experience
- (2017) Mami Momose et al. JOURNAL OF DERMATOLOGY
- Absolute PASI and its correlation with DLQI: An ex post analysis of the CLEAR study
- (2017) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study
- (2017) A. Körber et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of secukinumab in treating moderate to severe plaque psoriasis in two real-world Canadian dermatology clinics: a multicenter retrospective study
- (2017) J.R. Georgakopoulos et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
- (2017) Jillian Frieder et al. Therapeutic Advances in Chronic Disease
- Secukinumab: A Review in Psoriatic Arthritis
- (2016) Matt Shirley et al. DRUGS
- Safety of secukinumab in the treatment of psoriasis
- (2016) Andrew Blauvelt Expert Opinion On Drug Safety
- New and Emerging Therapies in Psoriasis
- (2016) Craig L. Leonardi et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Secukinumab: A Review in Moderate to Severe Plaque Psoriasis
- (2015) Karly P. Garnock-Jones AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up
- (2015) R.G. Langley et al. BRITISH JOURNAL OF DERMATOLOGY
- Secukinumab for treating plaque psoriasis
- (2015) Brooke Rothstein et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis
- (2013) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Risk of Serious Adverse Events Associated With Biologic and Nonbiologic Psoriasis Systemic Therapy
- (2012) Gregorio Carretero ARCHIVES OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now